Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 13/20 | 0.47 |
| ▸ | S1PR1 | P21453 | 13/20 | 0.47 |
| ▸ | S1PR3 | Q99500 | 13/20 | 0.47 |
| ▸ | S1PR4 | O95977 | 9/20 | 0.47 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.47 |
| ▸ | SAT1 | P21673 | 1/20 | 0.37 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 3/20 | 0.34 |
| ▸ | ANPEP | P15144 | 1/20 | 0.33 |
| ▸ | ERAP2 | Q6P179 | 1/20 | 0.33 |
| ▸ | CA12 | O43570 | 1/20 | 0.33 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2596914 | 0.98 | S1PR2 (0.46) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL7021919 | 0.83 | LPAR3 (0.45) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL16638748 | 0.83 | PPARD (0.43) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL57190 | 0.83 | CYP2C19 (0.38) | — | |
| SCHEMBL2596965 | 0.82 | S1PR2 (0.46) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL20875716 | 0.82 | LPAR3 (0.48) | S1PR2S1PR1S1PR3S1PR4S1PR5 | |
| SCHEMBL11311739 | 0.82 | CYP2C19 (0.31) | — | |
| SCHEMBL1092293 | 0.81 | CYP2C19 (0.36) | — | |
| Hydrochloric Acid SCHEMBL28741000 | 0.81 | CYP2C19 (0.36) | — | |
| Methyl Alcohol SCHEMBL29226019 | 0.81 | LPAR1 (0.45) | LPAR2CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11827807-B2 | Metal surface coatings for improving bond performance and methods of making the same | NOVELIS INC. (US) | 2023-11-28 | — | — | US | disclosed |
| US-11827807-B2 | Metal surface coatings for improving bond performance and methods of making the same | NOVELIS INC. (US) | 2023-11-28 | — | — | US | disclosed |
| US-11827807-B2 | Metal surface coatings for improving bond performance and methods of making the same | NOVELIS INC. (US) | 2023-11-28 | — | — | US | disclosed |
| EP-3997180-B1 | METAL SURFACE COATINGS FOR IMPROVING BOND PERFORMANCE AND METHODS OF MAKING THE SAME | NOVELIS INC (US) | 2023-08-30 | — | — | EP | disclosed |
| EP-3997180-A1 | METAL SURFACE COATINGS FOR IMPROVING BOND PERFORMANCE AND METHODS OF MAKING THE SAME | Novelis Inc. (US) | 2022-05-18 | — | — | EP | disclosed |
| WO-2021055076-A1 | METAL SURFACE COATINGS FOR IMPROVING BOND PERFORMANCE AND METHODS OF MAKING THE SAME | NOVELIS INC. (US) | 2021-03-25 | — | — | WO | disclosed |
| EP-2593496-A1 | POLYMER COMPOSITIONS CONTAINING ALKOXYSILANES | Dow Corning Corporation (US) | 2013-05-22 | — | — | EP | disclosed |
| US-20130065993-A1 | Polymer Compositions Containing Alkoxysilanes | DOW CORNING CORPORATION (US) | 2013-03-14 | — | — | US | disclosed |
| WO-2011143930-A1 | POLYMER COMPOSITIONS CONTAINING ALKOXYSILANES | DOW CORNING CORPORATIOM (US) | 2011-11-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11827807-B2 | Metal surface coatings for improving bond performance and methods of making the same | SOD1, AEBP2, ITGA8 | S1PR2 4654/4885S1PR1 4703/4885S1PR3 4753/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.